Cargando…
An immunization program for US-bound refugees: Development, challenges, and opportunities 2012–present
BACKGROUND: US-bound refugees undergo required health assessments overseas to identify and treat communicable diseases of public health significance—such as pulmonary tuberculosis—before migration. Immunizations are not required, leaving refugees at risk for vaccine-preventable diseases. In response...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590094/ https://www.ncbi.nlm.nih.gov/pubmed/33218780 http://dx.doi.org/10.1016/j.vaccine.2020.10.047 |
_version_ | 1784814441706029056 |
---|---|
author | Mitchell, Tarissa Dalal, Warren Klosovsky, Alexander Yen, Catherine Phares, Christina Burkhardt, Margaret Amin, Farah Froes, Ivan Hamadeh, Amira Lynn, Sai Aung Quintanilla, Judith Doney, Annelise Casano Cetron, Martin Weinberg, Michelle |
author_facet | Mitchell, Tarissa Dalal, Warren Klosovsky, Alexander Yen, Catherine Phares, Christina Burkhardt, Margaret Amin, Farah Froes, Ivan Hamadeh, Amira Lynn, Sai Aung Quintanilla, Judith Doney, Annelise Casano Cetron, Martin Weinberg, Michelle |
author_sort | Mitchell, Tarissa |
collection | PubMed |
description | BACKGROUND: US-bound refugees undergo required health assessments overseas to identify and treat communicable diseases of public health significance—such as pulmonary tuberculosis—before migration. Immunizations are not required, leaving refugees at risk for vaccine-preventable diseases. In response, the US Centers for Disease Control and Prevention and the US Department of State developed and co-funded a global immunization program for US-bound refugees, implemented in 2012 in collaboration with the International Organization for Migration. METHODS: We describe the Vaccination Program for US-bound Refugees, including vaccination schedule development, program implementation and procedures, and responses to challenges. We estimate 2019 immunization coverage rates using the number of age-eligible refugees who received ≥1 dose of measles-containing vaccine during overseas health assessment, and calculated hepatitis B infection prevalence using hepatitis B surface antigen testing results. We report descriptive data on adverse events following immunization. RESULTS: By September 2019, the program was active in >80 countries on five continents. Nearly 320,000 examined refugees had ≥1 documented vaccine doses since program inception. During federal fiscal year 2019, 95% of arriving refugees had ≥1 documented measles-containing vaccine. The program’s immunization schedule included eleven vaccines preventing fourteen diseases. In 2015–2019, only two vaccine preventable disease-associated refugee group travel cancellations occurred, compared to 2–8 cancellations annually prior to program initiation. To maintain uniform standards, dedicated staff and program-specific protocols for vaccination and monitoring were introduced. CONCLUSIONS: An overseas immunization program was successfully implemented for US-bound refugees. Due to reductions in refugee movement cancellation, lower cost of immunization overseas, and likely reductions in vaccine preventable disease-associated morbidity, we anticipate significant cost savings. Although maintaining uniform standards across diverse settings is challenging, solutions such as introduction of dedicated staff, protocol development, and ongoing technical support have ensured program cohesion, continuity, and advancement. Lessons learned can benefit similar programs implemented in the migration setting. |
format | Online Article Text |
id | pubmed-9590094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-95900942022-10-24 An immunization program for US-bound refugees: Development, challenges, and opportunities 2012–present Mitchell, Tarissa Dalal, Warren Klosovsky, Alexander Yen, Catherine Phares, Christina Burkhardt, Margaret Amin, Farah Froes, Ivan Hamadeh, Amira Lynn, Sai Aung Quintanilla, Judith Doney, Annelise Casano Cetron, Martin Weinberg, Michelle Vaccine Article BACKGROUND: US-bound refugees undergo required health assessments overseas to identify and treat communicable diseases of public health significance—such as pulmonary tuberculosis—before migration. Immunizations are not required, leaving refugees at risk for vaccine-preventable diseases. In response, the US Centers for Disease Control and Prevention and the US Department of State developed and co-funded a global immunization program for US-bound refugees, implemented in 2012 in collaboration with the International Organization for Migration. METHODS: We describe the Vaccination Program for US-bound Refugees, including vaccination schedule development, program implementation and procedures, and responses to challenges. We estimate 2019 immunization coverage rates using the number of age-eligible refugees who received ≥1 dose of measles-containing vaccine during overseas health assessment, and calculated hepatitis B infection prevalence using hepatitis B surface antigen testing results. We report descriptive data on adverse events following immunization. RESULTS: By September 2019, the program was active in >80 countries on five continents. Nearly 320,000 examined refugees had ≥1 documented vaccine doses since program inception. During federal fiscal year 2019, 95% of arriving refugees had ≥1 documented measles-containing vaccine. The program’s immunization schedule included eleven vaccines preventing fourteen diseases. In 2015–2019, only two vaccine preventable disease-associated refugee group travel cancellations occurred, compared to 2–8 cancellations annually prior to program initiation. To maintain uniform standards, dedicated staff and program-specific protocols for vaccination and monitoring were introduced. CONCLUSIONS: An overseas immunization program was successfully implemented for US-bound refugees. Due to reductions in refugee movement cancellation, lower cost of immunization overseas, and likely reductions in vaccine preventable disease-associated morbidity, we anticipate significant cost savings. Although maintaining uniform standards across diverse settings is challenging, solutions such as introduction of dedicated staff, protocol development, and ongoing technical support have ensured program cohesion, continuity, and advancement. Lessons learned can benefit similar programs implemented in the migration setting. 2021-01-03 2020-11-18 /pmc/articles/PMC9590094/ /pubmed/33218780 http://dx.doi.org/10.1016/j.vaccine.2020.10.047 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Article Mitchell, Tarissa Dalal, Warren Klosovsky, Alexander Yen, Catherine Phares, Christina Burkhardt, Margaret Amin, Farah Froes, Ivan Hamadeh, Amira Lynn, Sai Aung Quintanilla, Judith Doney, Annelise Casano Cetron, Martin Weinberg, Michelle An immunization program for US-bound refugees: Development, challenges, and opportunities 2012–present |
title | An immunization program for US-bound refugees: Development, challenges, and opportunities 2012–present |
title_full | An immunization program for US-bound refugees: Development, challenges, and opportunities 2012–present |
title_fullStr | An immunization program for US-bound refugees: Development, challenges, and opportunities 2012–present |
title_full_unstemmed | An immunization program for US-bound refugees: Development, challenges, and opportunities 2012–present |
title_short | An immunization program for US-bound refugees: Development, challenges, and opportunities 2012–present |
title_sort | immunization program for us-bound refugees: development, challenges, and opportunities 2012–present |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590094/ https://www.ncbi.nlm.nih.gov/pubmed/33218780 http://dx.doi.org/10.1016/j.vaccine.2020.10.047 |
work_keys_str_mv | AT mitchelltarissa animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT dalalwarren animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT klosovskyalexander animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT yencatherine animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT phareschristina animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT burkhardtmargaret animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT aminfarah animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT froesivan animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT hamadehamira animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT lynnsaiaung animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT quintanillajudith animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT doneyannelisecasano animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT cetronmartin animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT weinbergmichelle animmunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT mitchelltarissa immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT dalalwarren immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT klosovskyalexander immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT yencatherine immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT phareschristina immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT burkhardtmargaret immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT aminfarah immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT froesivan immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT hamadehamira immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT lynnsaiaung immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT quintanillajudith immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT doneyannelisecasano immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT cetronmartin immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present AT weinbergmichelle immunizationprogramforusboundrefugeesdevelopmentchallengesandopportunities2012present |